IP Library Granted Patent US 10,925,901
Granted Patent B2
US 10,925,901 · App. 16/235,392 · Granted Feb 23, 2021

Compositions containing platelet contents

Inventors: Allan B. Dietz (Chatfield, MN); Michael P. Gustafson (Rochester, MN); Greg W. Butler (Rochester, MN)
Assignee: Mayo Foundation for Medical Education and Research
A61K35/19C12N5/0037C12N5/0644C12N5/0662C12N5/0693C12N2500/90
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,925,901
App. No.
16/235,392
Granted
Feb 23, 2021
Kind
B2
Abstract

This document provides methods and materials relating to platelet lysates. For example, methods and materials for using platelet lysate compositions to grow adult stem cells, to differentiate adult stem cells, to grow primary cell cultures, to grow tumor stem cells, and to identify effective growth factors are provided.

Claims (17)

1. A stable human platelet lysate composition comprising:

a lysed platelet preparation comprising:

i) plasma,

ii) a total protein concentration of at least about 35 mg per mL,

iii) a protein fraction that contains growth factor activity;

iv) greater than 200 pg human VEGF per mL; and

wherein said platelet lysate composition comprises protein complexes greater than 50 kDa.

2. The platelet lysate composition of claim 1 , wherein the composition further comprises: about 180 pg/mL FGF.

3. The platelet lysate composition of claim 1 , wherein the composition further comprises: about 54 ng/mL TGF-β.

4. The platelet lysate composition of claim 1 , wherein the composition further comprises: about 8.5 ng/mL PDGF-BB.

5. The platelet lysate composition of claim 1 , wherein the composition further comprises: about 180 pg/mL FGF; about 8.5 ng/mL PDGF; about 132 ng/mL IGF-1; and about 54 ng/mL TGF-β.

6. The platelet lysate composition of claim 1 , wherein the total protein concentration is least about 48 mg per mL.

7. The platelet lysate composition of claim 1 , wherein the platelet lysate composition is passed through a 0.20 μm or smaller filter after begin filtered by a 0.45 μm or smaller filter.

8. The platelet lysate composition of claim 1 , wherein the composition further comprises heparin.

9. The platelet lysate composition of claim 1 , wherein the composition is a spray, glue, or a suture.

10. The platelet lysate composition of claim 8 , wherein the composition is a spray, glue, or a suture.

11. The platelet lysate composition of claim 1 , wherein the protein fraction has a molecular weight of greater than 100,000 daltons.

Continuity (4)
Continuation 14957914 · Dec 3, 2015
Continuation 13119350
Provisional Application 61097490 · Sep 16, 2008
Related Publication 20190209617A1 · Jul 11, 2019
Cited By (4)
US 12,258,576 US 12,324,816 US 12,371,657 US 12,576,109